FDA.reportPublic FDA data

ublituximab-xiiy 150 MG per 6 ML Injection

RxCUI
2626353
RxNorm name
ublituximab-xiiy 150 MG per 6 ML Injection
Display name
ublituximab-xiiy 150 MG per 6 ML Injection
Full name
ublituximab-xiiy 150 MG per 6 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761238Briumviublituximab-xiiy351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BRIUMVIUBLITUXIMABTG Therapeutics, Inc.3a77cd8c-811b-407c-9140-d0c5c26435c22026-02-19Warnings, Adverse reactionsExact identifier
rxcui: 2626353

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3a77cd8c-811b-407c-9140-d0c5c26435c2ublituximab-xiiy 150 MG in 6 ML Injection [PSN] · 6 ML ublituximab-xiiy 25 MG/ML Injection [SCD] · ublituximab-xiiy 150 MG per 6 ML Injection [SY]321These highlights do not include all the information needed to use BRIUMVI safely and effectively. See full prescribing information for BRIUMVI. BRIUMVI ® (ublituximab-xiiy) injection, for intravenous use Initial U.S. Approval: 202220260219